Livedoid vasculitis - Vaskulitis Livedoid
https://en.wikipedia.org/wiki/Livedoid_vasculitis
☆ AI Dermatology — Free ServiceIng asil Stiftung Warentest 2022 saka Jerman, kepuasan konsumen karo ModelDerm mung luwih murah tinimbang konsultasi telemedicine sing dibayar. 

Bisa dibarengi dengan lara.
relevance score : -100.0%
References
Livedoid vasculopathy: A review with focus on terminology and pathogenesis 36285834 NIH
Livedoid vasculopathy yaiku kondisi kulit langka sing ditandai dening ulkus nyeri sing terus-terusan muncul ing sikil ngisor.
Livedoid vasculopathy (LV) is a rare thrombotic vasculopathy of the dermis characterized by painful, relapsing ulcers over the lower extremities. Diagnosis is challenging due to the overlap in clinical appearance and nomenclature with other skin disorders. Treatment selection is complicated by poor understanding of the pathogenesis of LV and lack of robust clinical trials evaluating therapy efficacy. The terminology and pathophysiology of LV are reviewed here, along with its epidemiology, clinical and histologic features, and treatment options. A diagnostic pathway is suggested to guide providers in evaluating for comorbidities, referring to appropriate specialists, and choosing from the available classes of therapy.
Livedoid vasculopathy: A review of pathogenesis and principles of management 27297279Livedoid vasculopathy yaiku kondisi kulit langka sing nyebabake ulkus ambal ing sikil ngisor lan ninggalake bekas pucet sing dikenal minangka atrophie blanche. Sanajan panyebab sing tepat durung jelas, dipercaya manawa hypercoagulability minangka faktor utama, kanthi inflamasi nduweni peran sekunder. Faktor‑faktor sing nyumbang marang pembekuan kalebu deficiencies in proteins C and S, genetic mutations kaya factor V Leiden, antithrombin III deficiency, prothrombin gene mutations, lan tingkat homocysteine sing dhuwur. Ing biopsi, kondisi iki nuduhake gumpalan getih ing jero pembuluh, penebalan tembok pembuluh, lan jaringan parut. Perawatan meliputi pendekatan multi‑cabang sing fokus kanggo nyegah pembekuan getih kanthi obat‑obatan anti‑trombosit, pengencer getih, lan terapi fibrinolitik. Macam‑macam obat sing bisa digunakake kanggo kondisi kulit iki antara liya colchicine lan hydroxychloroquine, vasodilators, lan immunosuppressants.
Livedoid vasculopathy is a rare skin condition that causes recurring ulcers on the lower legs, leaving behind pale scars known as atrophie blanche. While the exact cause is still unclear, it's believed that increased blood clotting (hypercoagulability) is the main factor, with inflammation playing a secondary role. Factors contributing to clotting include as follows - deficiencies in proteins C and S, genetic mutations like factor V Leiden, antithrombin III deficiency, prothrombin gene mutations, high levels of homocysteine. In biopsies, the condition shows blood clots inside vessels, thickening of vessel walls, and scarring. Treatment involves a multi-pronged approach focusing on preventing blood clots with medications like anti-platelet drugs, blood thinners, and fibrinolytic therapy. Various drugs can be used for this skin condition - colchicine and hydroxychloroquine, vasodilators, immunosuppressants.
Livedoid Vasculopathy 32644463 NIH
Livedoid vasculopathy minangka kondisi langka ing ngendi lesi muncul ing loro sikil. Pembentukan gumpalan getih ing pembuluh getih cilik diyakini disebabake dening peningkatan koagulasi lan penurunan fibrinolisis, bebarengan karo kerusakan lapisan pembuluh. Kondisi iki luwih umum ing wanita, utamane antara umur 15 nganti 50 taun. Menghentikan merokok, merawat luka, lan nggunakake obat-obatan kayata pengencer getih lan obat antiplatelet wis kabukti efektif.
Livedoid vasculopathy is a rare vasculopathy that is typically characterized by bilateral lower limb lesions. Increased thrombotic activity and decreased fibrinolytic activity along with endothelial damage are believed to be the cause of thrombus formation in the capillary vasculature. It is 3 times more common in females than in males, especially in patients between the ages of 15 to 50 years. There is no definite first-line treatment, but general measures like smoking cessation, wound care, and pharmacological measures like anticoagulants and antiplatelets have shown good results.